KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Times Interest Earned (2017 - 2022)

Sarepta Therapeutics has reported Times Interest Earned over the past 6 years, most recently at -$15.97 for Q4 2022.

  • Quarterly results put Times Interest Earned at -$15.97 for Q4 2022, down 68.52% from a year ago — trailing twelve months through Sep 2023 was -$59.7 (down 476.85% YoY), and the annual figure for FY2023 was -$12.17, down 20.84%.
  • Times Interest Earned for Q4 2022 was -$15.97 at Sarepta Therapeutics, up from -$20.78 in the prior quarter.
  • Over the last five years, Times Interest Earned for SRPT hit a ceiling of -$1.67 in Q3 2021 and a floor of -$444.11 in Q1 2019.
  • Median Times Interest Earned over the past 5 years was -$10.34 (2020), compared with a mean of -$34.41.
  • Biggest five-year swings in Times Interest Earned: tumbled 10929.44% in 2019 and later soared 98.05% in 2020.
  • Sarepta Therapeutics' Times Interest Earned stood at -$19.23 in 2018, then tumbled by 42.73% to -$27.44 in 2019, then surged by 75.83% to -$6.63 in 2020, then crashed by 42.95% to -$9.48 in 2021, then crashed by 68.52% to -$15.97 in 2022.
  • The last three reported values for Times Interest Earned were -$15.97 (Q4 2022), -$20.78 (Q3 2022), and -$12.45 (Q2 2022) per Business Quant data.